Arvee Laboratories (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2025.

Revenue growth above 20%Profit growth above 25%Negative operating cash flowRelated-party transactionsResults View source PDF Explain this filing

ARVEE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.7%Reaction day

₹149.94

prior close

₹150.21

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+4.6%-8.3% vs market

Specialty Chemicals peers, median of 81sector+3.9%-7.6% vs sector

On the reaction day the stock moved 8.3 pts less than Nifty Microcap 250 and 7.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.8

15m

-0.8

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.7+4.6-8.3+3.9-7.6

Next day

-4.0+6.3-10.3+4.5-8.5

-1.3+8.1-9.4+5.8-7.1

+5.4+9.1-3.8+7.0-1.6

+0.7+10.0-9.3+7.2-6.5

-0.9+11.3-12.2+8.9-9.8

+5.4+11.0-5.6+8.7-3.4

15d

+34.3+13.3+21.0+9.2+25.2

+15.6+15.3+0.4+13.0+2.7

+24.7+17.0+7.8+11.7+13.0

+12.7+11.4+1.3+7.2+5.5

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 81Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Arvee Laboratories' board approved FY25 audited results showing revenue from operations of ₹3,848.72 lakhs, up about 27% from ₹3,034.52 lakhs in FY24, while profit after tax more than doubled to ₹214.74 lakhs (FY24: ₹105.18 lakhs), lifting EPS to ₹1.95 from ₹0.95. However, Q4 performance was muted — revenue was nearly flat at ₹645 lakhs and Q4 PAT actually fell to ₹6.92 lakhs from ₹11.60 lakhs a year earlier. The statutory auditors (Nirav Patel & Associates) issued an unmodified opinion on the results. A worrying point is that operating cash flow swung sharply negative to ₹(3.73) lakhs versus ₹670.79 lakhs in FY24, and cash and bank balances dropped to ₹21.10 lakhs from ₹185.01 lakhs. The board also re-appointed internal auditors and appointed M/s. Jalan Alkesh & Associates as secretarial auditor for a 5-year term starting April 1, 2025.

Likely market impact

The strong full-year revenue and profit growth are positive for shareholders, but the steep fall in operating cash flow and the 89% drop in cash balance raise red flags about working-capital pressure and near-term liquidity. Q4 weakness and the need to watch cash generation closely temper the otherwise encouraging earnings story.